BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11339545)

  • 1. Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction.
    Takahashi M; Kamiya H; Asano Y; Shiraki K; Baba K; Otsuka T; Hirota T; Yamanishi K
    Arch Virol Suppl; 2001; (17):161-72. PubMed ID: 11339545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.
    Trannoy E; Berger R; Holländer G; Bailleux F; Heimendinger P; Vuillier D; Creusvaux H
    Vaccine; 2000 Feb; 18(16):1700-6. PubMed ID: 10689152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen.
    Takahashi M; Iketani T; Sasada K; Hara J; Kamiya H; Asano Y; Baba K; Shiraki K
    J Infect Dis; 1992 Aug; 166 Suppl 1():S58-62. PubMed ID: 1320651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.
    Baba K; Shiraki K; Kanesaki T; Yamanishi K; Ogra PL; Yabuuchi H; Takahashi M
    J Clin Microbiol; 1987 Nov; 25(11):2193-6. PubMed ID: 2826535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
    Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
    Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double-blind, placebo-controlled trial.
    Hata A; Inoue F; Hamamoto Y; Yamasaki M; Fujikawa J; Kawahara H; Kawasaki Y; Honjo S; Koshiyama H; Moriishi E; Mori Y; Ohkubo T
    Diabet Med; 2016 Aug; 33(8):1094-101. PubMed ID: 26605507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A relationship between varicella-zoster virus-specific delayed hypersensitivity and varicella-zoster virus-induced anterior uveitis.
    Kezuka T; Sakai J; Minoda H; Takeuchi M; Keino H; Streilein JW; Usui M
    Arch Ophthalmol; 2002 Sep; 120(9):1183-8. PubMed ID: 12215092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibility of prevention of herpes zoster by use of varicella vaccine].
    Kawano S; Terada K; Yagi Y; Kataoka N
    Kansenshogaku Zasshi; 1998 Jul; 72(7):714-9. PubMed ID: 9745221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.
    Levin MJ; Oxman MN; Zhang JH; Johnson GR; Stanley H; Hayward AR; Caulfield MJ; Irwin MR; Smith JG; Clair J; Chan IS; Williams H; Harbecke R; Marchese R; Straus SE; Gershon A; Weinberg A;
    J Infect Dis; 2008 Mar; 197(6):825-35. PubMed ID: 18419349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed-type hypersensitivity and in vitro lymphocyte response in guinea pigs immunized with a live varicella vaccine.
    Shiraki K; Yamanishi K; Takahashi M; Dohi Y
    Biken J; 1984 Mar; 27(1):19-22. PubMed ID: 6091616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
    Berger R; Luescher D; Just M
    Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections.
    Källander CF; Torfason EG; Olding-Stenkvist E; Sundqvist VA; Diderholm H; Gronowitz JS
    J Med Virol; 1989 May; 28(1):30-7. PubMed ID: 2542443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain.
    Asada H; Nagayama K; Okazaki A; Mori Y; Okuno Y; Takao Y; Miyazaki Y; Onishi F; Okeda M; Yano S; Kumihashi H; Gomi Y; Maeda K; Ishikawa T; Iso H; Yamanishi K;
    J Dermatol Sci; 2013 Mar; 69(3):243-9. PubMed ID: 23183011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay.
    Takahashi M; Okada S; Miyagawa H; Amo K; Yoshikawa K; Asada H; Kamiya H; Torigoe S; Asano Y; Ozaki T; Terada K; Muraki R; Higa K; Iwasaki H; Akiyama M; Takamizawa A; Shiraki K; Yanagi K; Yamanishi K
    Vaccine; 2003 Sep; 21(25-26):3845-53. PubMed ID: 12922118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
    Levin MJ; Smith JG; Kaufhold RM; Barber D; Hayward AR; Chan CY; Chan IS; Li DJ; Wang W; Keller PM; Shaw A; Silber JL; Schlienger K; Chalikonda I; Vessey SJ; Caulfield MJ
    J Infect Dis; 2003 Nov; 188(9):1336-44. PubMed ID: 14593591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.
    Takayama M
    Med Microbiol Immunol; 1994 Feb; 183(1):1-11. PubMed ID: 8202026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella-zoster virus-specific immunity after herpes zoster.
    Hayward A; Levin M; Wolf W; Angelova G; Gilden D
    J Infect Dis; 1991 Apr; 163(4):873-5. PubMed ID: 1849165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.
    Levin MJ; Schmader KE; Pang L; Williams-Diaz A; Zerbe G; Canniff J; Johnson MJ; Caldas Y; Cho A; Lang N; Su SC; Parrino J; Popmihajlov Z; Weinberg A
    J Infect Dis; 2016 Jan; 213(1):14-22. PubMed ID: 26452397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to varicella-zoster virus in Thai children and young adults.
    Kositanont U; Wasi C; Oonsombat P; Suvatte V; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):414-20. PubMed ID: 3006266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.